The best way to fund startups is not to give them money but to build infrastructure that fuels and supports their investors.
Industry
Vocxi Health, which undergoes a merger this week, advanced to the Startup World Cup last year for a breath-sensor device.
Peytant Solutions’ version of a stent, never before commercialized, received FDA approval in 2024.
Vail Scientific’s point-of-care device, awaiting FDA clearance, could reduce deadly delays in sepsis detection.
Latest Articles
Vail Scientific’s point-of-care device, awaiting FDA clearance, could reduce deadly delays in sepsis detection.
The Minnesota Climate Innovation Finance Authority doesn’t want public money. It wants authorization to receive private investments.
Along with the major influx of new members following UCare's collapse, Medica contends with pressures besetting all health insurers.
The downtown Minneapolis building is coming back to life for creative types under the vision of Kristi Oman.
He plans to bring market-rate apartments and retail to the corner of Snelling and University.
They said AI would replace women. These Minnesotans didn't get the memo.
A Lutheran church wants to build a brewery and coffeehouse in place of its original building—to treat post-pandemic loneliness, apply a “parish” philosophy to Lynnhurst, and self-sustain as a nonprofit.
Now a veteran CEO, Barry originally brushed off the idea of leading the giant retailer.
Current CEO Corie Barry departs the Richfield-based electronics retailer as planned at the end of Q3.
Nucleus plans to expand capabilities at Rochester facility and finish construction of new site near Philadelphia.
With AI optimism and an empathy-based leadership style, Gorder wants to bring Minneapolis back to the top of the creative-agency market.
Partner and CEO of Rise and Shine and Partners shares his favorite social media follows.
Inside the race to solve the PFAS problem, and why Claros thinks it will win.
NeuroOne developed OneRF to treat epilepsy and recently took first steps to expand its use.
Phillips Distilling produces Sour Puss, a liqueur whose hot reputation in Canada was jeopardized by the Trump tariffs.